IP Library Assignment 061283/0526
Patent Assignment
Reel/Frame 061283/0526

Change of Name

Recorded: 2022-08-19 Pages: 5
Assignor
ELSTAR THERAPEUTICS, INC.
Executed: 2021-01-29
Assignee
MARENGO THERAPEUTICS, INC.
840 MEMORIAL DRIVE, 4TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (7)
Anti-Tcr Antibody Molecules and Uses Thereof
Application: 17/820,634 →
Publication: US 2023/0025484
METHOD OF TREATING SOLID CANCERS WITH BISPECIFIC INTERLEUKIN-ANTI-TCRß MOLECULES
Application: 17/820,794 →
Publication: US 2023/0272074
Anti-Tcr Antibody Molecules and Uses Thereof
Application: 17/820,800 →
Publication: US 2023/0127740
Anti-Tcr Antibody Molecules and Uses Thereof
Application: 17/820,805 →
Publication: US 2023/0174650
Anti-Tcr Antibody Molecules and Uses Thereof
Application: 17/820,806 →
Publication: US 2023/0034161
Anti-Tcr Antibody Molecules and Uses Thereof
Application: 17/820,811 →
Publication: US 2023/0142522
Anti-Tcr Antibody Molecules and Uses Thereof
Application: 17/820,818 →
Publication: US 2023/0031734
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 19, 2022
From: TAN, SENG-LAI; VASH, BRIAN EDWARD; HSU, JONATHAN; GUNASEKERA, DILINI CHARMAIN
To: ELSTAR THERAPEUTICS, INC.
Reel/Frame 061283/0084 →